A review of Phase I trials of Ebolavirus vaccines: What can we learn from the race to develop novel vaccines?
Sporadic outbreaks of Ebolavirus infection have been documented since the mid-seventies and viral exposure can lead to lethal haemorrhagic fever with case fatalities as high as 90%. There is now a comprehensive body of data from both ongoing and completed clinical trials assessing various vaccine s...
| Hauptverfasser: | , , |
|---|---|
| Format: | Journal article |
| Veröffentlicht: |
Royal Society
2017
|